by clearskymd | Apr 13, 2022 | Company News
ClearSky Medical Diagnostics recently attended and exhibited at the 35th Global Conference of Alzheimer’s Disease International in June 2022. The hybrid conference, hosted online and in-person at The Kia Oval in London, took place from 9 to 11 June 2022 with the...
by clearskymd | Mar 24, 2022 | Company News
ClearSky Medical Diagnostics has developed an intelligent medical device that can objectively diagnose mild cognitive impairment (MCI), a condition often suggested as an early stage of dementia. It is estimated that between five and 20 per cent of people aged over 65...
by clearskymd | Jan 11, 2022 | Company News
ClearSky Medical Diagnostics is supporting a new initiative to better understand the development of children’s brains during their early stages of life. The Wellcome Leap Program’s The First 1000 Days – Promoting Healthy Brain Networks project focuses on the...
by clearskymd | Dec 8, 2021 | Company News
ClearSky Medical Diagnostics and Shanghai Accurature Diagnostics Co Ltd have entered into a strategic cooperation agreement related to PD-Monitor. PD-Monitor is a medical device using ClearSky’s proprietary AI technology to assist the diagnosis and measurements of...
by clearskymd | Dec 14, 2020 | Company News
Professor Stephen Smith highlighted the work of ClearSky Medical Diagnostics in diagnosing and monitoring Parkinson’s at a UK–China university consortium in November. The UK-Jiangsu World-Class University Consortium is a group of more than 30 leading...
by clearskymd | Nov 16, 2020 | Company News
ClearSky’s PD-Monitor has been used in a major UK study to investigate whether statins are effective in slowing the progress of Parkinson’s. Statins, such as Simvastatin, are a group of medicines that are currently prescribed to lower cholesterol in the blood....
Recent Comments